HCWB
HCW Biologics Inc.
Key Financials
Operating Income
$-13162510
↑ 55.4%
Gross Profit
$10846
↓ 98.9%
EPS (Diluted)
$-10.63
↓ 1280.5%
Total Liabilities
$21.8M
↓ 41.2%
Revenue
$6.7M
N/A
Total Assets
$24.5M
↓ 18.9%
Shareholders' Equity
$2.8M
↑ 140.8%
Cash & Equivalents
$2.0M
↓ 58.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-1 | 10/2/2026 | View on SEC |
| DEF 14A | 10/1/2026 | View on SEC |
| 8-K | 9/24/2026 | View on SEC |
| 8-K | 9/10/2026 | View on SEC |
| PRER14A | 9/9/2026 | View on SEC |
| 8-K | 9/8/2026 | View on SEC |
| PRE 14A | 9/8/2026 | View on SEC |
| EFFECT | 8/31/2026 | View on SEC |
| S-1/A | 8/28/2026 | View on SEC |
| S-1 | 8/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HCWB |
| Company Name | HCW Biologics Inc. |
| CIK | 1828673 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 954-842-2024 |